PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung Cancer
NCT03971214
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Extensive-stage Small Cell Lung Cancer
Radiotherapy
Immunotherapy
Interventions
DRUG:
PD-1 inhibitor JS-001
Sponsor
Chinese Academy of Medical Sciences